Anti-MUC1 Antibody Enhanced Helper and Cytolytic T Cell Responses with Human Dendritic Cells Presenting MUC1 Antigen or MUC1-Positive Tumor Cells

BC Schultes

AACR, Minisymposium, 2005

In Vitro Culture System to Study Chemo-Immunotherapy Synergy

BC Schultes, F Hou, LM Smith, CF Nicodemus

AAI 2006, 142.13

Induction of Helper And Cytolytic T Cell Responses in Muc1-Tg Mice Immunized With MUC1-Anti-MUC1 Immune Complexes

BC Schultes, LM Smith, CF Nicodemus, P Mukherjee, SJ Gendler

AACR 2006, Abstract #1401

Immunization with Muc1-Anti-Muc1 Immune Complexes Induces CD4 And CD8 T Cell Responses and Provides Tumor Control in Muc1-Tg Mice. AACR 2007,

BC Schultes, F Hou, LM Smith, CF Nicodemus

Abstract #5097.

Structural Basis for Antigen Recognition of a Tumor Specific Therapeutic Antibody. Antibody Engineering and Therapeutics, The Antibody Society’s Annual Meeting

M Movahedin, TM Brooks, CL Brooks

Dec 8-12, 2014.

Conformational Selection Mediates High Affinity Binding of a MUC1 Specific Antibody to a Glycopeptide Antigen. The Antibody Society’s Annual Meeting

R Movahedin, TM Brooks, N Supekar, GJ Boons, CL Brooks

Dec 7-10, 2015.

AR20.5 based novel immunotherapy for pancreatic cancer

K Mehla, JA Grunkemeyer, KA O’Connell, T Caffrey, R Madiyalakan, CF Nicodemus, MA Hollingsworth

AACR 2016.

Glycosylation of MUC1 and antibody binding. Keystone Symposium - Antibodies as Drugs: Translating Molecules Into Treatments

Brooks, C.L.

Feb. 25 – Mar 1, 2018.